Clinical Documentation Improvement Market Report 2026

The clinical documentation improvement market size has grown strongly in recent years. It will grow from $4.3 billion in 2025 to $4.65 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to increasing regulatory compliance requirements, rising complexity of medical coding systems, expansion of electronic medical records adoption, growing emphasis on accurate reimbursement, early use of documentation review programs.

The clinical documentation improvement market size is expected to see strong growth in the next few years. It will grow to $6.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing adoption of ai-driven documentation tools, rising focus on value-based care models, expansion of remote and cloud-based cdi services, growing investments in healthcare data analytics, increasing demand for clinical workflow optimization. Major trends in the forecast period include increasing adoption of nlp-based cdi software, rising integration with ehr platforms, growing use of automated coding and auditing tools, expansion of cloud-based cdi solutions, enhanced focus on documentation accuracy.

The rising burden of chronic diseases is expected to drive the growth of the clinical documentation improvement market in the coming years. The increase in chronic conditions is largely attributed to aging populations, lifestyle factors such as unhealthy diets and physical inactivity, and the growing prevalence of risk factors including obesity and smoking. Clinical documentation improvement supports effective chronic disease management by ensuring accurate and comprehensive patient records, which enable better care coordination, informed treatment planning, and improved patient outcomes. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, approximately 194 million adults in the United States, representing 76.4% of the population, reported having at least one chronic condition in 2023. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93% among older adults. Therefore, the increasing burden of chronic diseases is contributing to the growth of the clinical documentation improvement market.

Major companies operating in the clinical documentation improvement market are increasingly focusing on advanced technologies such as generative artificial intelligence-based medical documentation to improve accuracy, efficiency, and overall documentation quality. Generative AI-based medical documentation involves the use of artificial intelligence to automatically generate, manage, and enhance patient medical records. For example, in April 2024, Augmedix Inc., a US-based provider of AI-driven medical documentation and data solutions, launched Augmedix Go, a fully automated generative AI-powered documentation solution designed for emergency departments. This solution improves the patient experience at the point of care, enhances provider productivity through higher-quality documentation, reduces the cognitive burden associated with note-taking, and shortens chart completion time.

In October 2025, R1, a US-based healthcare technology and revenue cycle management company, partnered with Phare Health to automate mid-cycle revenue operations. This collaboration is intended to streamline and optimize revenue processes, improve operational efficiency, and enhance financial performance for healthcare providers, while also promoting innovation in healthcare revenue cycle management. Phare Health is a US-based health technology company that specializes in intelligent automation solutions for clinical and revenue workflows.

Major companies operating in the clinical documentation improvement market are Optum Inc., 3M Company, Cerner Corporation, Epic Systems Corporation, GEBBS Healthcare Solutions Private Limited, CorroHealth Inc., Accuity Holdings, Nuance Communications Inc, AGS Health Private Limited, Aquity Solutions India Private Limited, Vizient Inc., Health Catalyst Inc., The Craneware Group Inc., Optimum Healthcare IT LLC., Claro Healthcare LLC., Iodine Software LLC, Health Fidelity Inc., Vitalware LLC., Streamline Healthcare Solutions Private Limited, Medaxiom Cardiology LLC, Dolbey Systems Inc., ChartWise Medical Systems Inc., Qventus Inc.

North America was the largest region in the clinical documentation improvement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical documentation improvement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical documentation improvement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical documentation improvement market by increasing costs of imported IT hardware, data storage systems, analytics engines, and supporting infrastructure used in CDI software deployments. Healthcare providers in North America and Europe are most affected due to reliance on imported servers and data processing equipment, while Asia-Pacific faces cost pressure on cloud infrastructure services. These tariffs are increasing implementation costs and delaying technology upgrades. However, they are also encouraging cloud-first CDI adoption, regional software development, and increased use of subscription-based CDI platforms that minimize dependence on physical hardware.

The clinical documentation improvement market research report is one of a series of new reports that provides clinical documentation improvement market statistics, including clinical documentation improvement industry global market size, regional shares, competitors with a clinical documentation improvement market share, detailed clinical documentation improvement market segments, market trends and opportunities, and any further data you may need to thrive in the clinical documentation improvement industry. This clinical documentation improvement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical documentation improvement (CDI) is the process of improving the accuracy, completeness, and clarity of clinical documentation within healthcare environments. The objective of CDI is to ensure that medical records accurately represent a patient’s clinical condition, treatments, and outcomes, which is critical for delivering high-quality patient care, achieving accurate medical coding, securing appropriate reimbursement, and maintaining compliance with regulatory requirements.

The primary products and services in clinical documentation improvement include solutions and consulting services. Clinical documentation improvement solutions consist of tools and methodologies designed to enhance the accuracy, completeness, and overall quality of medical records, supporting improved patient care and adherence to regulatory standards. These solutions are delivered through on-premise and cloud-based deployment models and are used by end users such as healthcare providers and healthcare payers.

The clinical documentation improvement market includes revenues earned by entities by providing services such as review and analysis, coding support, education and training, compliance monitoring, query management, and data analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.